Biopharma News : Biopharma and Pharma news from all around the world :
- Fauna Bio Announces Target Designation Milestone in Obesity Discovery Collaboration
- Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results
- Additional Phase 2 Data of AL-S Pharma’s Lead Program AP-101 Further Demonstrate Clinically Meaningful Disease Modification and Prolonged Survival in ALS
- FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
- Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock
- GE HealthCare completes Intelerad acquisition – accelerating shift to cloud-first enterprise solutions to deliver precision care
- Nia Therapeutics Receives FDA Breakthrough Device Designation for AI-Guided Brain Implant to Treat Memory Loss
- Dyno Therapeutics Launches Dyno Psi-Phi, an Agentic AI Suite for Protein Binder Design, at NVIDIA GTC 2026
- QHP Announces $1.1 Billion Continuation Vehicle for Azurity Pharmaceuticals
- Mave Health Raises $2.1M to Launch Focus and Stress Regulation Wearable
- Blue Matter Launches People and Organization Practice to Help Biopharma Navigate Structural Shift
- Tiny Cargo and Bio-Sourcing Partner to Develop First-of-Its-Kind Oral Monoclonal Antibody Platform Using Goat-Milk Exosomes
- Open Molecular Software Foundation’s OpenFold Consortium Launches Research Fellowship at the University of Washington’s Institute for Protein Design
- Niagen Bioscience to Present at the 38th Annual ROTH Conference
- Crossbow Therapeutics Raises $77 Million in Series B Financing to Advance Development of TCR-mimetic Antibody Therapies to Treat Cancer
- RevnaBio Secures Triple International Laboratory Accreditation to Expand Precision Medicine and Clinical Research Infrastructure in Africa
- KERENDIA® (finerenone) Meets Primary Endpoint in Investigational Phase III FIND-CKD Study in Patients with Non-Diabetic Chronic Kidney Disease
- Samsung Bioepis and Epis NexLab Sign Research Collaboration and License Agreement with G2GBIO to Develop Novel Assets Including Long-acting Semaglutide
- YolTech Therapeutics Receives FDA Clearance to Initiate Phase 2/3 Study of In Vivo Gene-Editing Therapy YOLT-202 in Alpha-1 Antitrypsin Deficiency (AATD)
- ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors
- AOM Infusion Selected as a Limited Distribution Specialty Pharmacy for QIVIGY®, A New Immune Globulin Therapy
- TIXiMED Announces Expansion of Program-Related Investment from the Helmsley Charitable Trust
- Aptar Pharma and COVIRIX Medical Partner to Develop Inhalable Antiviral Treatments
- Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026
- Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal®
- Combat Medical Raises £2.6 Million Series A to Advance Treatment of BCG Unresponsive Bladder Cancer
- Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation’s 2026 Antimicrobial Resistance Benchmark Report
- Centauri Therapeutics Granted FDA QIDP Status for CTX-187 Treatment of Gram-Negative Bacterial Infections
- Alzheon to Present Clinical, Imaging, and Fluid Biomarker Results from Trials with Oral Valiltramiprosate/ALZ-801 at 2026 AD/PD Conference in Copenhagen, Denmark
- For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 2025
News about Biotech, Pharma, Biopharma, Medical Devices, Diagnostics, Digital Health
- Marinomed Biotech AG has decided to conduct a cash capital increase to cover short-term capital requirements of approximately EUR 2 million
- MEDICLIN invites you to the 2026 virtual press conference on the financial statements for the year 2025
- Secarna Pharmaceuticals establishes Advisory Board with financial markets expert Jens Holstein and shareholder representative Richard Mark Engelhard
- Pentixapharm Holding AG will publish its financial report for the 2025 fiscal year on March 26, 2026
- Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
- Viromed Medical AG: Anna Heinen appointed to the Supervisory Board
- PolyPeptide strengthens financing structure through expansion of existing credit facility
- DocMorris and Google partner to advance one of Europe’s leading AI-powered digital health platform
- DocMorris achieves 2025 targets – focus on profitability, growth and expansion of digital health platform
- Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 Finance Contract
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank
- aap successfully completes MDR certification: All existing products approved according to MDR – market access in the EU and CE-relevant markets secured in the long term
- Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025
- Darwin AG launches commercialization of Multi-Cancer Check — a blood test for early detection of 13 types of cancer
- Sandoz announces partnership agreement with Samsung Bioepis on up to five biosimilars, further expanding its leading pipeline to up to 32 assets
- Newron announces nominations to its Board of Directors at upcoming Annual General Meeting
- BioVersys Reports Corporate Highlights and Financial Results for the Full Year 2025
- Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China
- Cantourage Group SE publishes preliminary figures for 2025 – Revenue rises to EUR 92.8 million
- Medartis builds on momentum with 16% organic sales growth and core EBITDA margin exceeding 18%
- PolyPeptide publishes invitation to the annual General Meeting 2026
- Sartorius Stedim Biotech sharpens strategy with biopharma focus and sets new mid-term growth targets
- Major Milestone CF PHARMTECH, INC. 2652.HK Announces IND Acceptance for PAH New Drug with a Globally Innovative Improved Mechanism, Marking Another Milestone for Its Precision Drug Delivery Platform
- Chia Tai Enterprises International Proposes Name Change to CPBIO Biotech is the Core Growth Engine: Innovation Fuels Diversified Portfolio
- BIO-Europe Spring® 2026: Partnering Momentum Builds as Global Biopharma Leaders Set Course for Lisbon
- NVision and Aarhus University Awarded Innovation Fund Denmark Grant to Advance Clinical Translation of Quantum-Enhanced MRI
- BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start
- Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives
- Medacta Group SA: Medacta Group reports record results in Full Year 2025 and upgrades mid-term guidance
- Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation
- New partnership to fast-track Canadian health technology from innovation to patient care
- Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions
- Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions
- New partnership to fast-track Canadian health technology from innovation to patient care
- The Endothelial Glycocalyx Explained: How It Helps Regulate Vascular Function
- OKYO Pharma Announces Chairman and Founder Acquires Shares
- The Endothelial Glycocalyx Explained: How It Helps Regulate Vascular Function
- OKYO Pharma Announces Chairman and Founder Acquires Shares
- Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss
- Notice to convene Evaxion’s Annual General Meeting
- Curia Expands Glasgow Manufacturing Capacity and Enhances Cell Line Development Platform
- Oncolytics Biotech® to Present New Mechanistic and Translational Data Supporting Pelareorep as an Immune-Priming Backbone at AACR 2026
- Sol-Gel Files Annual Report on Form 20-F for the Year Ended December 31, 2025
- Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder
- BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair
- SK pharmteco Reaffirms Three-Business-Unit Strategy, Strengthens Global Gene Therapy Business Unit with Funding Commitment
- Persica Pharmaceutical’s PP353 Phase 1b Data Selected for Oral Presentation at the American Society of Interventional Pain Physicians (ASIPP) 2026 Annual Meeting
- Roquette’s 2025 results show the resilience of its expanded portfolio in a very difficult market environment
- Dr. Myung Ju Lee of VIP Plastic Surgery Receives Minister of Health and Welfare Award at Medical Korea 2026
- Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
- 2026 MAP Awards presented to 20 organizations for high performance in revenue cycle
- VitalHub Reports Fourth Quarter 2025 Results
- Alvotech Q4 2025 and Full Year 2025 Financial Results
- Alvotech Q4 2025 and Full Year 2025 Financial Results
- Extendicare Announces Proposed Changes to Board of Directors
- Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
- Azalea Therapeutics Highlights Nature Publication Demonstrating In Vivo Site-Specific TRAC-CAR T Cell Engineering
- Totus Medicines Presents Phase 1a Clinical Data for TOS-358, a Covalent PI3Ka Inhibitor, at ESMO TAT 2026
- Centre for Neuro Skills Expands Employer Partnerships Strategy, Appoints Jay Varma as Director
- Cortisol Detox App Supports Healthy Fat Loss With Meal Plans and Mindfulness
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites for more info.
Biopharma News – Pharma News